This week's highlights
Equity markets started to improve last week as investors mulled over further fiscal stimulus packages. The Aussie dollar depreciated strongly over the week. BetaShares Strong US Dollar Hedge Fund (YANK) was the week’s top performing fund, returning 9.3%. Technology and related funds also saw strong weekly performance, with FANG, TECH and NDQ all amongst the top performers. Long USD products ZUSD and USD were also amongst the top ten performers. Long Aussie dollar product (AUDS) was the worst performer down -12.9%. Precious metal funds ETPMAG and ETPMPT were all amongst the week’s poorest performers, along with energy fund (FUEL) and Gold Miners (MNRS).
Total reported flows into domestically domiciled ETFs were $1.045bn, which was well above average, while outflows totalled $38m. Domestic equity fund IOZ saw the biggest inflows for the week, A$624.4m, followed by A200. South Korean equity fund IKO saw the week’s largest outflows.
IOZ was the most traded fund for the week, followed by BBOZ and VAS.
ETFS S&P Biotech ETF (CURE) offers investors direct exposure to biotechnology a sub-sector of healthcare. CURE invests in US biotechnology companies that are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Examples include the development of immunotherapy treatments and vaccines to treat human diseases.